The latest news from oncology events around the world
A multicenter Phase II clinical trial has demonstrated significant tumour shrinkage and disease control in patients…
Patients with oestrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with…
Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful…
A drug that harnesses the immune system to attack cancer cells has proved successful in…
A sneak preview podcast of what to expect from the AGITG’s 2025 ASM!
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy…
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Blood cancer patients in the US who may have previously struggled to find a donor…
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.